Lanreotide (Deamidized)

Lanreotide (Deamidized) is a synthetic peptide analog derived from somatostatin, engineered with a specific deamidation modification that subtly alters its molecular structure while preserving the core bioactive properties. As a research-grade carbohydrate compound, Lanreotide (Deamidized) is valued for its stability, ease of handling, and its ability to mimic the biological activity of endogenous somatostatin in various in vitro and in vivo experimental systems. The deamidized form is particularly useful in studies where understanding the impact of post-translational modifications on peptide function is crucial, as deamidation can influence peptide conformation, receptor affinity, and metabolic stability. Its unique structure enables researchers to dissect the nuanced roles of peptide modifications in cell signaling, receptor interaction, and peptide degradation pathways, supporting advanced investigations in peptide chemistry and molecular pharmacology.

Peptide-receptor interaction studies: Lanreotide (Deamidized) serves as a valuable tool for elucidating the binding dynamics between somatostatin analogs and their corresponding G protein-coupled receptors (GPCRs). By comparing the binding affinity and signaling efficacy of deamidized versus non-deamidized forms, scientists can better understand how post-translational modifications affect receptor recognition and downstream signaling events. This application is particularly relevant in pharmacological profiling and receptor subtype selectivity studies, where subtle structural differences can have significant functional consequences.

Peptide stability and degradation assays: Researchers utilize Lanreotide (Deamidized) to investigate the impact of deamidation on peptide stability under physiological and experimental conditions. By subjecting both native and deamidized peptides to enzymatic or chemical degradation assays, it is possible to assess how structural modifications influence susceptibility to proteolytic cleavage, half-life, and metabolic fate. Such studies are essential for optimizing peptide analogs for research and therapeutic development, as they provide insights into the mechanisms governing peptide turnover and bioavailability.

Structure-activity relationship (SAR) analysis: The deamidized variant of Lanreotide is instrumental in SAR studies aimed at correlating molecular modifications with biological activity. By systematically evaluating how deamidation alters the interaction with target receptors and downstream effectors, researchers can identify critical structural features responsible for activity modulation. This approach facilitates the rational design of novel somatostatin analogs with tailored pharmacological profiles, supporting drug discovery and development efforts in endocrine and neuroendocrine research.

Cell signaling pathway exploration: Lanreotide (Deamidized) is employed in cellular assays to dissect the influence of peptide modifications on intracellular signaling cascades. By monitoring changes in second messenger levels, phosphorylation events, or gene expression profiles following receptor activation, investigators can delineate the specific contributions of deamidation to functional selectivity and signal transduction. These studies enhance our understanding of how structural variants of peptide hormones regulate complex cellular responses and may reveal new targets for intervention in dysregulated signaling pathways.

Analytical method development: The unique properties of Lanreotide (Deamidized) make it an excellent standard or reference compound for developing and validating analytical techniques, such as high-performance liquid chromatography (HPLC), mass spectrometry, and immunoassays. Its use enables researchers to optimize detection sensitivity, specificity, and quantification accuracy for modified peptides, supporting robust quality control and characterization protocols in peptide research laboratories.

Lanreotide (Deamidized) continues to be a pivotal resource for scientists investigating the multifaceted effects of peptide modifications on biological activity, receptor interaction, and analytical detection. Its application in receptor binding studies, stability assays, SAR analysis, cell signaling exploration, and method development underscores its versatility and importance in advancing peptide science. By providing a deeper understanding of how structural changes like deamidation influence peptide function, Lanreotide (Deamidized) contributes significantly to the development of next-generation peptide analogs, improved analytical methodologies, and the broader field of molecular pharmacology.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet